Our top pick for
Building a portfolio
Galecto, Inc is a biotechnology business based in the US. Galecto shares (GLTO) are listed on the NASDAQ and all prices are listed in US Dollars. Galecto employs 28 staff and has a market cap (total outstanding shares value) of USD0.00.
|52-week range||USD$5.77 - USD$17.99|
|50-day moving average||USD$7.9884|
|200-day moving average||USD$12.0748|
|Wall St. target price||USD$15.75|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||N/A|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|Gross profit TTM||USD$0|
|Return on assets TTM||-18.43%|
|Return on equity TTM||-32.56%|
|Market capitalisation||USD$154.6 million|
TTM: trailing 12 months
There are currently 71,413 Galecto shares held short by investors – that's known as Galecto's "short interest". This figure is 49% up from 47,924 last month.
There are a few different ways that this level of interest in shorting Galecto shares can be evaluated.
Galecto's "short interest ratio" (SIR) is the quantity of Galecto shares currently shorted divided by the average quantity of Galecto shares traded daily (recently around 43544.512195122). Galecto's SIR currently stands at 1.64. In other words for every 100,000 Galecto shares traded daily on the market, roughly 1640 shares are currently held short.
To gain some more context, you can compare Galecto's short interest ratio against those of similar companies.
However Galecto's short interest can also be evaluated against the total number of Galecto shares, or, against the total number of tradable Galecto shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Galecto's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Galecto shares in existence, roughly 0 shares are currently held short) or 0.0042% of the tradable shares (for every 100,000 tradable Galecto shares, roughly 4 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Galecto.
Find out more about how you can short Galecto stock.
We're not expecting Galecto to pay a dividend over the next 12 months.
You may also wish to consider:
Galecto, Inc. , a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a life-threatening progressive fibrotic disease of the lung. Its products also comprise GB2064, which is in Phase I/IIa for the treatment of myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase I/IIa for the treatment of cancer and fibrosis. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark. .
Features, fees and complaints to consider before you apply for a T. Rowe Price account.
Steps to owning and managing ZTO, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZOM, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZI, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZKIN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZION, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZIONL, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZNTL, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZGYH, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZEAL, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.